Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mortalite Infantile Reduite Par l'Administration de Masse de l'Azitromycine

NCT04716712 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT04716712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04716712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mortalite Infantile Reduite Par l'Administration de Masse de l'Azitromycine
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Active, not recruiting
Start date
October 4, 2021
Completion date
January 30, 2026
Enrollment
Not reported
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

child mortality